Wegovy Is Least Cost-Effective Weight Loss Drug for Teens in Study

 

• Wegovy is less cost-effective than other drugs, study finds
• Novo Nordisk’s weight loss drug costs $1,349 a month in the US

Novo Nordisk A/S’s blockbuster weight loss drug Wegovy is not remotely cost effective when compared to other weight-loss drugs for teens, a new study suggests.

Researchers from Columbia University modeled 100,000 adolescent patients with obesity to determine the cost-effectiveness of different weight-loss drugs. While Wegovy helped teenage patients lose the most weight, its $1,349 monthly cost made it a less appealing option than older, cheaper drugs, according to findings published Thursday in JAMA Network Open.

https://www.bloomberg.com/news/articles/2023-08-31/wegovy-is-least-cost-effective-teen-weight-loss-drug-in-study